Carol Giltner Gallagher - Jun 23, 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Director
Signature
/s/ David Tucker, Attorney-in-Fact
Stock symbol
ATRA
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/27/2022, 04:48 PM
Previous filing
Jun 16, 2021
Next filing
Aug 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Award $0 +20.5K +18.32% $0.00 132K Jun 23, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATRA Non-Qualified Stock Option (Right to Buy) Award $0 +31.5K $0.00 31.5K Jun 23, 2022 Common Stock 31.5K $7.35 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
F2 The amount of securities beneficially owned by the reporting person shown here corrects an inadvertent understatement of 100 shares in a prior Form 4.
F3 The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.